Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/6772
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tsilimigras, D. I. | - |
dc.contributor.author | Moris, D. | - |
dc.contributor.author | Hyer, J. M. | - |
dc.contributor.author | Bagante, F. | - |
dc.contributor.author | Ratti, F. | - |
dc.contributor.author | Marques, H. P. | - |
dc.contributor.author | Soubrane, O. | - |
dc.contributor.author | Lam, Vincent W. T. | - |
dc.contributor.author | Poultsides, G. A. | - |
dc.contributor.author | Popescu, I. | - |
dc.contributor.author | Alexandrescu, S. | - |
dc.contributor.author | Martel, G. | - |
dc.contributor.author | Workneh, A. | - |
dc.contributor.author | Guglielmi, A. | - |
dc.contributor.author | Hugh, T. | - |
dc.contributor.author | Aldrighetti, L. | - |
dc.contributor.author | Endo, I. | - |
dc.contributor.author | Pawlik, T. M. | - |
dc.date.accessioned | 2023-04-06T04:06:56Z | - |
dc.date.available | 2023-04-06T04:06:56Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Annals of Surgical Oncology 28(12):7673-7683, 2021 | - |
dc.identifier.uri | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/6772 | - |
dc.description.abstract | INTRODUCTION: Although preoperative alpha-fetoprotein (AFP) has been recognized as an important tumor marker among patients with hepatocellular carcinoma (HCC), the predictive value of AFP levels at the time of recurrence (rAFP) on post-recurrence outcomes has not been well examined. METHODS: Patients undergoing curative-intent resection of HCC between 2000 and 2017 were identified using a multi-institutional database. The impact of rAFP on post-recurrence survival, as well as the impact of rAFP relative to the timing and treatment of HCC recurrence were examined. RESULTS: Among 852 patients who underwent resection of HCC, 307 (36.0%) individuals developed a recurrence. The median rAFP level was 8 ng/mL (interquartile range 3-100). Among the 307 patients who developed recurrence, 3-year post-recurrence survival was 48.5%. Patients with rAFP > 10 ng/mL had worse 3-year post-recurrence survival compared with individuals with rAFP < 10 ng/mL (28.7% vs. 65.5%, p < 0.001). rAFP correlated with survival among patients who had early (3-year survival; rAFP > 10 vs. < 10 ng/mL: 30.1% vs. 60.2%, p < 0.001) or late (18.0% vs. 78.7%, p = 0.03) recurrence. Furthermore, rAFP levels predicted 3-year post-recurrence survival among patients independent of the therapeutic modality used to treat the recurrent HCC (rAFP > 10 vs. < 10 ng/mL; ablation: 41.1% vs. 76.0%; intra-arterial therapy: 12.9% vs. 46.1%; resection: 37.5% vs. 100%; salvage transplantation: 60% vs. 100%; all p < 0.05). After adjusting for competing risk factors, patients with rAFP > 10 ng/mL had a twofold higher hazard of death in the post-recurrence setting (hazard ratio 1.96, 95% confidence interval 1.26-3.04). CONCLUSION: AFP levels at the time of recurrence following resection of HCC predicted post-recurrence survival independent of the secondary treatment modality used. Evaluating AFP levels at the time of recurrence can help inform post-recurrence risk stratification of patients with recurrent HCC. | - |
dc.title | Serum alpha-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma | - |
dc.type | Journal Article | - |
dc.identifier.doi | https://dx.doi.org/10.1245/s10434-021-09977-x | - |
dc.subject.keywords | Carcinoma, Hepatocellular | - |
dc.subject.keywords | Liver Neoplasms | - |
dc.subject.keywords | Neoplasm Recurrence, Local | - |
dc.subject.keywords | alpha-Fetoproteins | - |
dc.identifier.journaltitle | Annals of Surgical Oncology | - |
dc.identifier.department | Surgery | - |
dc.identifier.pmid | 33907924 | - |
dc.contributor.wslhd | Lam, Vincent W. T. | - |
dc.identifier.facility | Westmead | - |
Appears in Collections: | Westmead Hospital 2019 - 2024 |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.